Compare ALP & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALP | MTNB |
|---|---|---|
| Founded | N/A | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 5.2M |
| IPO Year | N/A | 2014 |
| Metric | ALP | MTNB |
|---|---|---|
| Price | $0.24 | $0.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 19.8K |
| Earning Date | N/A | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $119,750.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.23 | $0.48 |
| 52 Week High | $0.30 | $3.09 |
| Indicator | ALP | MTNB |
|---|---|---|
| Relative Strength Index (RSI) | 25.87 | 41.10 |
| Support Level | $0.23 | $0.57 |
| Resistance Level | $0.27 | $0.65 |
| Average True Range (ATR) | 0.02 | 0.05 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 15.87 | 12.01 |
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.